Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Resmed Inc before investing.

In this article, we go over a few key elements for understanding Resmed Inc’s stock price such as:

• Resmed Inc’s current stock price and volume
• Why Resmed Inc’s stock price changed recently
• Upgrades and downgrades for RMD from analysts
• RMD’s stock price momentum as measured by its relative strength

About Resmed Inc (RMD)

Before we jump into Resmed Inc’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

ResMed Inc. is a holding company. The Company, through its subsidiaries, is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. The Company’s segments include Sleep and Respiratory Care and Software as a Service. SDB includes obstructive sleep apnea and other respiratory disorders that occur during sleep. Its cloud-based digital software health applications, along with its devices, are designed to provide connected care to improve patient outcomes. Its portfolio of products includes devices, diagnostic products, mask systems, headgear and other accessories, dental devices, and cloud-based software and informatics solutions. Its comprehensive out-of-hospital software platforms support the professionals and caregivers.

Want to learn more about Resmed Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Resmed Inc.

Resmed Inc’s Stock Price as of Market Close

As of April 17, 2024, 4:00 PM, CST, Resmed Inc’s stock price was $173.83.

Resmed Inc is down 5.97% from its previous closing price of $184.86.

During the last market session, Resmed Inc’s stock traded between $183.37 and $186.72. Currently, there are 147.13 million shares of Resmed Inc stock available for purchase.

Resmed Inc’s price-earnings (P/E) ratio is currently at 30.6, which is low compared to the Advanced Medical Equipment & Technology industry median of 35.8. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Resmed Inc Stock Price History

Resmed Inc’s (RMD) price is currently down 12.22% so far this month.

During the month of April, Resmed Inc’s stock price has reached a high of $198.31 and a low of $172.19.

Over the last year, Resmed Inc has hit prices as high as $243.52 and as low as $132.24. Year to date, Resmed Inc’s stock is down 16.48%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Resmed Inc Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of April 16, 2024, there were 2 analysts who downgraded Resmed Inc’s stock and 6 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Resmed Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Resmed Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Resmed Inc’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Resmed Inc (RMD) by visiting AAII Stock Evaluator.

Relative Price Strength of Resmed Inc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of April 16, 2024, Resmed Inc has a weighted four-quarter relative price strength of -5.88%, which translates to a Momentum Score of 47 and is considered to be Average.

Want to learn more about how Resmed Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Resmed Inc Stock Price: Bottom Line

As of April 17, 2024, Resmed Inc’s stock price is $173.83, which is down 5.97% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Resmed Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.